Global lenders team up with Stephen Saad’s Aspen on $711-million COVID-19 vaccine deal
The consortium hopes to help Africa avoid continued hoarding of COVID-19 vaccines by developed countries.
Stephen Saad
South African billionaire Stephen Saad’s stake in Aspen Pharmacare gains $168.9 million
Aspen is a global multinational pharmaceutical company.